A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.).


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 24 01 2019
accepted: 26 07 2019
revised: 15 07 2019
pubmed: 8 8 2019
medline: 13 11 2019
entrez: 8 8 2019
Statut: ppublish

Résumé

An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is crucial for the choice of proper treatment. Presently, precise recognition of these disorders relies on the combination of morphological, immunophenotypical, and cytogenetic/molecular features. The diagnostic workup in such situations implies the application of costly and time-consuming analyses, which are not always required, since an intensified treatment option is reasonably reserved to fit patients. The Italian Group of Haematopathology proposes herein a practical algorithm for the diagnosis of aggressive mature B cell lymphomas based on a stepwise approach, aimed to select cases deserving molecular analysis, in order to optimize time and resources still assuring the optimal management for any patient.

Identifiants

pubmed: 31388760
doi: 10.1007/s00428-019-02637-2
pii: 10.1007/s00428-019-02637-2
pmc: PMC6828632
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-518

Commentaires et corrections

Type : ErratumIn

Références

Blood. 2017 Jan 19;129(3):280-288
pubmed: 27821509
Nature. 2000 Feb 3;403(6769):503-11
pubmed: 10676951
Haematologica. 2019 Jan;104(1):e25-e28
pubmed: 29954940
J Clin Oncol. 2012 Oct 1;30(28):3460-7
pubmed: 22665537
Blood. 2015 Nov 26;126(22):2466-74
pubmed: 26373676
Blood. 2011 May 5;117(18):4836-43
pubmed: 21441466
Histopathology. 2013 Sep;63(3):418-24
pubmed: 23795946
Haematologica. 2018 Nov;103(11):1899-1907
pubmed: 29903764
Blood. 2018 May 3;131(18):2060-2064
pubmed: 29475959
J Clin Oncol. 2019 Jan 20;37(3):175-177
pubmed: 30523718
Am J Surg Pathol. 2012 Apr;36(4):612-9
pubmed: 22314191
J Clin Oncol. 2012 Oct 1;30(28):3452-9
pubmed: 22851565
Blood. 2004 Jan 1;103(1):275-82
pubmed: 14504078
Oncotarget. 2015 Mar 20;6(8):5615-33
pubmed: 25760242

Auteurs

Arianna Di Napoli (A)

Pathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University, Via di Grottarossa 1035, 00189, Rome, Italy. arianna.dinapoli@uniroma1.it.

D Remotti (D)

Pathology Unit, San Camillo-Forlanini Hospital, Rome, Italy.

C Agostinelli (C)

Hematopathology Unit, S. Orsola University Hospital, Bologna, Italy.

M R Ambrosio (MR)

Pathology Unit, Department of Medical Biotechnology, University of Siena, Siena, Italy.

S Ascani (S)

Pathology Unit, Ospedale di Terni, University of Perugia, Terni, Italy.

A Carbone (A)

Department of Pathology, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.

F Facchetti (F)

Pathology Section, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

S Lazzi (S)

Pathology Unit, Department of Medical Biotechnology, University of Siena, Siena, Italy.

L Leoncini (L)

Pathology Unit, Department of Medical Biotechnology, University of Siena, Siena, Italy.

M Lucioni (M)

Pathology Unit, University of Pavia and Fondazione IRCCS San Matteo Policlinico, Pavia, Italy.

D Novero (D)

Department of Oncology, University of Turin and Pathology Unit, AOU Città della Salute e della Scienza, Turin, Italy.

S Pileri (S)

Division of Haematopathology, European Institute of Oncology, Milan, Italy.

M Ponzoni (M)

Ateneo Vita-Salute, Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

E Sabattini (E)

Hematopathology Unit, S. Orsola University Hospital, Bologna, Italy.

C Tripodo (C)

Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.
Tumor and Microenvironment Histopathology Unit, the FIRC Institute of Molecular Oncology (IFOM), Milan, Italy.

A Zamò (A)

Department of Oncology, University of Turin and Pathology Unit, AOU Città della Salute e della Scienza, Turin, Italy.

M Paulli (M)

Pathology Unit, University of Pavia and Fondazione IRCCS San Matteo Policlinico, Pavia, Italy.
Italian Group of Haematopathology (GIE), Rome, Italy.

L Ruco (L)

Pathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University, Via di Grottarossa 1035, 00189, Rome, Italy.
Pathology Board of the Italian Lymphoma Foundation (FIL), Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH